Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    17426277 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Immunogenicity and Safety of Trivalent Recombinant Hemagglutinin Influenza Vaccine in Healthy Adults
Condition: Influenza
Intervention: Biological: Influenza Vaccine, recombinant Hemagglutinin

Study has passed its completion date and status has not been verified in more than two years.